Molecular Mimicry of Host Glycosylated Structures by Bacteria

Microbial Glycobiology

Volumn , Issue , 2010, Pages 847-870

  Moran, Anthony P ^a,b  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^b GRIFFITH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882886663     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-374546-0.00043-2     Document Type: Chapter

References (149)

1. Abu-Shakra M., Buskila D., Shoenfeld Y. Molecular mimicry between host and pathogen: examples from parasites and implication. Immunol. Lett. 1999, 67:147-152.
2. Amano K.-I., Hayashi S., Kubota T., Fujii N., Yokota S.-I. Reactivities of Lewis antigen monoclonal antibodies with the lipopolysaccharides of Helicobacter pylori strains isolated from patients with gastroduodenal diseases in Japan. Clin. Diagn. Lab. Immnunol. 1997, 4:540-544.
3. + -adenosine triphosphatase in human gastric autoimmunity. J. Exp. Med. 2003, 198:1147-1156.
4. 1 antibodies in rabbits. J. Neuroimmunol. 2000, 104:133-138.
5. Ang C.W., Jacobs B.C., Laman J.D. The Guillain-Barré syndrome: a true case of molecular mimicry. Trends Immunol. 2004, 25:61-66.
6. Appelmelk B.J., Simoons-Smit I., Negrini R., et al. Potential role of molecular mimicry between Helicobacter pylori lipopolysaccharide and host Lewis blood group antigens in autoimmunity. Infect. Immun. 1996, 64:2031-2040.
7. Appelmelk B.J., Faller G., Claeys D., Kirchner T., Vandenbroucke-Grauls C.M.J.E. Bugs on trial: the case of Helicobacter pylori and autoimmunity. Immunol. Today 1998, 19:296-299.
8. Appelmelk B.J., Martin S.L., Monteiro M.A., et al. Phase variation in Helicobacter pylori lipopolysaccharide due to changes in the lengths of poly(C) tracts in α3-fucosyltransferase genes. Infect. Immun. 1999, 67:5361-5366.
9. Appelmelk B.J., Monteiro M.A., Martin S.L., Moran A.P., Vandenbroucke-Grauls C.M.J.E. Why Helicobacter pylori has Lewis antigens. Trends Microbiol. 2000, 8:565-570.
10. Aspinall G.O., Lynch C.M., Pang H., Shaver R.T., Moran A.P. Chemical structures of the core region of Campylobacter jejuni O:3 lipopolysaccharide and an associated polysaccharide. Eur. J. Biochem. 1995, 231:570-578.
11. Aspinall G.O., Monteiro M.A., Pang H., Walsh E.J., Moran A.P. Lipopolysaccharide of the Helicobacter pylori type strain NCTC 11637 (ATCC 43504): structure of the O antigen chain and core oligosaccharide regions. Biochemistry 1996, 35:2489-2497.
12. Bergman M.P., Engering A., Smits H.H., et al. Helicobacter pylori modulates the T helper cell 1/T helper cell 2 balance through phase-variable interaction between lipopolysaccharide and DC-SIGN. J. Exp. Med. 2004, 200:979-990.
13. Bergman M., Del Prete G., van Kooyk Y., Appelmelk B. Helicobacter pylori phase variation, immune modulation and gastric autoimmunity. Nat. Rev. Microbiol. 2006, 4:151-159.
14. Britton S., Papp-Szabo E., Simala-Grant J., Morrison L., Taylor D.E., Monteiro M.A. A novel Helicobacter pylori cell-surface polysaccharide. Carbohydr. Res. 2005, 340:1605-1611.
15. Broutet N., Moran A., Hynes S., Sakarovitch C., Mégraud F. Lewis antigen expression and other pathogenic factors in the presence of atrophic chronic gastritis in a European population. J. Infect. Dis. 2002, 185:503-512.
16. Censini S., Lange C., Xiang Z., et al. cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. Proc. Natl. Acad Sci. USA 1996, 93:14648-14653.
17. +-ATPase is a major autoantigen in chronic Helicobacter pylori gastritis with body mucosa atrophy. Gastroenterology 1998, 115:340-347.
18. Cornblath D.R., Griffin D.E., Welch D., Griffin J.W., McArthur J.C. Quantitative analysis of endoneurial T-cells in human sural nerve biopsies. J. Neuroimmunol. 1990, 26:113-118.
19. D'Elios M.M., Appelmelk B.J., Amedei A., Bergman M.P., del Prete G. Gastric autoimmunity: the role of Helicobacter pylori and molecular mimicry. Trends Mol. Med. 2004, 10:316-323.
20. De Libero G.O., Moran A.P., Gober H.J., et al. Bacterial infections promote T cell recognition of self-glycolipids. Immunity 2005, 22:763-772.
21. Eaton K.A., Logan S.M., Baker P.E., Peterson R.A., Monteiro M.A., Altman E. Helicobacter pylori with a truncated lipopolysaccharide O-chain fails to induce gastritis in SCID mice injected with splenocytes from wild-type C57BL/6J mice. Infect. Immun. 2004, 72:3925-3931.
22. Ebringer A., Rashid T., Wilson C. Bovine spongiform encephalopathy, multiple sclerosis, and Creutzfeldt-Jakob disease are probably autoimmune diseases evoked by Acientobacter bacteria. Ann. N.Y. Acad. Sci. 2005, 1050:417-428.
23. Ebringer A., Rashid T., Jawad N., Wilson C., Thompson E.J., Ettelaie C. From rabies to transmissible spongiform encephalopathies: an immune-mediated microbial trigger involving molecular mimicry could be the answer. Med. Hypotheses 2007, 68:113-124.
24. Ebringer A., Rashid T., Tiwana H., Wilson C. A possible link between Crohn's disease and ankylosing spondylitis via Klebsiella infections. Clin. Rheumatol. 2007, 26:289-297.
25. Edwards N.J., Monteiro M.A., Faller G., et al. Lewis X structures in the O antigen side-chain promote adhesion of Helicobacter pylori to the gastric epithelium. Mol. Microbiol. 2000, 35:1530-1539.
26. Ernst P.B., Gold B.D. The disease spectrum of H. pylori: the immunopathogenesis of gastroduodenal ulcer and gastric cancer. Annu. Rev. Microbiol. 2000, 54:615-640.
27. Faé K.C., da Silva D.D., Oshiro S.E., et al. Mimicry in recognition of cardiac myosin peptides by heart-intralesional T cell clones from rheumatic heart disease. J. Immunol. 2006, 176:5662-5670.
28. Faller G., Steininger H., Kränzlein J., et al. Antigastric autoantibodies in Helicobacter pylori infection: implications of histological and clinical parameters of gastritis. Gut 1997, 41:619-623.
29. Faller G., Steininger H., Appelmelk B., Kirchner T. Evidence of novel pathogenic pathways for the formation of antigastric autoantibodies in Helicobacter pylori gastritis. J. Clin. Pathol. 1998, 51:244-245.
30. Feasby T.E., Hahn A.F., Gilbert J.J. Passive transfer studies in Guillain-Barré polyneuropathy. Neurology 1982, 32:1159-1167.
31. Fowler M., Thomas R.J., Atherton J., Roberts I.S., High N.J. Galectin-3 binds to Helicobacter pylori O-antigen: it is upregulated and rapidly secreted by gastric epithelial cells in response to H. pylori adhesion. Cell. Microbiol. 2006, 8:44-54.
32. Gilbert M., Parker C.T., Moran A.P. Campylobacter jejuni lipooligosaccharides: structure and biosynthesis. Campylobacter 2008, 483-504. ASM Press, Washington, DC. 3rd edn. I. Nachamkin, C.M. Szymanski, M.J. Blaser (Eds.).
33. Goodyear C.S., O'Hanlon G.M., et al. Monoclonal antibodies raised against Guillain-Barré syndrome-associated Campylobacter jejuni lipopolysaccharides react with neuronal gangliosides and paralyze muscle-nerve preparations. J. Clin. Invest. 1999, 104:697-708.
34. Green C. The ABO, Lewis and related blood group antigens: a review of structure and biosynthesis. FEMS Microbiol. Immunol. 1989, 47:321-330.
35. Guerry P., Szymanski C.M., Prendergast M.M., et al. Phase variation of Campylobacter jejuni 81-176 lipooligosaccharide affects ganglioside mimicry and invasiveness in vitro. Infect. Immun. 2002, 70:787-793.
36. Plasmapheresis and acute Guillain-Barré syndrome 1985. Neurology 1985, 35:1096-1104. Guillain-Barré syndrome Study Group.
37. Guiney D.G., Hasegawa P., Cole S.P. Helicobacter pylori preferentially induces interleukin 12 (IL-12) rather than IL-6 or IL-10 in human dendritic cells. Infect. Immun. 2003, 71:4136-4163.
38. Guruge J.L., Falk P.G., Lorenz R.G., et al. Epithelial attachment alters the outcome of Helicobacter pylori infection. Proc. Natl. Acad. Sci. USA 1998, 95:3925-3930.
39. Harrison B.M., Hansen L.A., Pollard J.D., McLeod J.G. Demyelination induced by serum from patients with Guillain-Barré syndrome. Ann. Neurol. 1984, 15:163-170.
40. Heneghan M.A., McCarthy C.F., Moran A.P. Is colonisation of gastric mucosa by Helicobacter pylori strains expressing Lewis x and y epitopes dependent on host secretor status?. Campylobacter, Helicobacter and Related Organisms 1998, 473-477. Institute of Child Health and University of Cape Town, Cape Town. A.J. Lastovica, D.G. Newell, E.E. Lastovica (Eds.).
41. Heneghan M.A., Moran A.P., Feeley K.M., et al. Effect of host Lewis and ABO blood group antigen expression on Helicobacter pylori colonisation density and the consequent inflammatory response. FEMS Immunol. Med. Microbiol. 1998, 20:257-266.
42. Heneghan M.A., McCarthy C.F., Moran A.P. Relationship of blood group determinants on Helicobacter pylori lipopolysaccharide with host Lewis phenotype and inflammatory response. Infect. Immun. 2000, 68:937-941.
43. Heneghan M.A., McCarthy C.F., Janulaityte D., Moran A.P. Relationship of anti-Lewis x and anti-Lewis y antibodies in serum samples from gastric cancer and chronic gastritis patients to Helicobacter pylori-mediated autoimmunity. Infect. Immun. 2001, 69:4774-4781.
44. Hogan E.L., Barry T., Dasgupta S., et al. Possible mycoplasma infection in MS: study of immunogenic glycolipids and search for mycoplasma DNA. Abstracts of the FEMS International Conference on Chlamydia and Mycoplasma Human Infections 2007, 57. University of Ferrara, Italy.
45. Hughes R.A.C., Cornblath D.R. Guillain-Barré syndrome. Lancet 2005, 366:1653-1666.
46. Hughes L.E., Bonell S., Natt R.S., et al. Antibody responses to Acinetobacter spp. and Pseudomonas aeruginosa in multiple sclerosis: prospects for diagnosis using the myelin-acinetobacter-neurofilament antibody index. Clin. Diagn. Lab. Immunol. 2001, 8:1181-1188.
47. Hynes S.O., Moran A.P. Comparison of three serological methods for detection of Lewis antigens on the surface of Helicobacter pylori. FEMS Microbiol. Lett. 2000, 190:67-72.
48. Hynes S.O., Keenan J.I., Ferris J.A., Annuk H., Moran A.P. Lewis epitopes on outer membrane vesicles of relevance to Helicobacter pylori pathogenesis. Helicobacter 2005, 10:146-156.
49. Illa I., Ortiz N., Gallard E., Juarez C., Grau J.M., Dalakas M.C. Acute axonal Guillain-Barré syndrome with IgG antibody against motor axons following parenteral gangliosides. Ann. Neurol. 1995, 38:218-224.
50. Ilver D., Arnqvist A., Ogren J., et al. Helicobacter pylori adhesin binding fucosylated histo-blood group antigens revealed by retagging. Science 1998, 279:373-377.
51. Isenberg D., Morrow J. Friendly Fire. Explaining Autoimmune Disease 1995, Oxford University Press, Oxford.
52. Karlyshev A.J., Wren B.J., Moran A.P. Campylobacter jejuni capsular polysaccharide. Campylobacter 2008, 505-521. ASM Press, Washington, DC. 3rd edn. I. Nachamkin, C.M. Szymanski, M.J. Blaser (Eds.).
53. Keenan J.I., Peterson R.A., Fraser R., et al. The effect of Helicobacter pylori infection and dietary iron deficiency on host iron homeostasis: a study in mice. Helicobacter 2004, 9:643-650.
54. Keenan J.I., Davis K.A., Beaugie C.R., McGovern J.J., Moran A.P. Alterations in Helicobacter pylori outer membrane and outer membrane vesicle-associated lipopolysaccharides under iron-limiting growth conditions. Innate Immun. 2008, 14:279-290.
55. Khalili-Shirazi A., Gregson N., Gray I.A., Rees J.H., Winer J.B., Hughes R.A.C. Anti-ganglioside antibodies in Guillain-Barré syndrome following recent cytomegalovirus infection. J. Neurol. Neurosurg. Psychiatr. 1999, 66:376-379.
56. Khamri W., Moran A.P., Worku M.L., et al. Variations in Helicobacter pylori lipopolysaccharide to evade the innate immune component surfactant protein D. Infect. Immun. 2005, 73:7677-7686.
57. Khamri W., Worku M.L., Anderson A.E., et al. Helicobacter infection in the surfactant protein D-deficient mouse. Helicobacter 2007, 12:112-123.
58. Knirel Y.A., Kocharova N.A., Hynes S.O., et al. Structural studies on lipopolysaccharides of serologically non-typable strains of Helicobacter pylori, AF1 and 007, expressing Lewis antigenic determinants. Eur. J. Biochem. 1999, 266:123-131.
59. Kobayashi K., Sakamoto J., Kito T., et al. Lewis blood group-related antigen expression in normal gastric epithelium, intestinal metaplasia, gastric adenoma, and gastric carcinoma. Am. J. Gastroenterol. 1993, 88:919-924.
60. Kocharova N.A., Knirel Y.A., Widmalm G., Jansson P.-E., Moran A.P. Structure of an atypical O-antigen polysaccharide of Helicobacter pylori containing a novel monosaccharide 3-C-methyl-d-mannose. Biochemistry 2000, 39:4755-4760.
61. Kusters J.G., van Vliet A.H.M., Kuipers E.J. Pathogenesis of Helicobacter pylori infection. Clin. Microbiol. Rev. 2006, 19:449-490.
62. 1b is a new member of antigen for serum antibody in Guillain-Barré syndrome. Neurology 1996, 47:237-242.
63. Kuwabara S., Misawa S., Takahashi H., et al. Anti-GQ1b antibody does not affect neuromuscular transmission in human limb muscle. J. Neuroimmunol. 2007, 189:158-162.
64. Latov N. Antibodies to glycoconjugates in neurological disease. Clin. Aspects Autoimmun. 1990, 4:18-29.
65. Li C.Y., Xue P., Tian W.Q., Liu R.C., Yang C. Experimental Campylobacter jejuni infection in the chicken: an animal model of axonal Guillain-Barré syndrome. J. Neurol. Neurosurg. Psychiatr. 1996, 61:279-284.
66. Logan S.M., Conlan J.W., Monteiro M.A., Wakarchuk W.W., Altman E. Functional genomics of Helicobacter pylori: identification of a β-1,4-galactosyltransferase and generation of mutants with altered lipopolysaccharide. Mol. Microbiol. 2000, 35:1156-1167.
67. Ma B., Simala-Grant J.L., Taylor D.E. Fucosylation in prokaryotes and eukaryotes. Glycobiology 2006, 16:158R-184R.
68. Ma J.Y., Borch K., Sjöstrand S.E., Janzon L., Mårdh S. Positive correlation between H,K-adenosine triphosphatase autoantibodies and Helicobacter pylori antibodies in patients with pernicious anemia. Scand. J. Gastroenterol. 1994, 29:961-965.
69. Mahdavi J., Sondén B., Hurtig M., et al. Helicobacter pylori SabA adhesin in persistent infection and chronic inflammation. Science 2002, 297:573-578.
70. Mahdavi J., Borén T., Vandenbroucke-Grauls C., Appelmelk B.J. Limited role of lipopolysaccharide Lewis antigens in adherence of Helicobacter pylori to the human gastric epithelium. Infect. Immun. 2003, 71:2876-2880.
71. Marrack P., Kappler J., Kotzin B.L. Autoimmune disease: why and where it occurs. Nat. Med. 2001, 7:899-905.
72. Marshall D.G., Hynes S.O., Coleman D.C., O'Morain C.A., Smyth C.J., Moran A.P. Lack of a relationship between Lewis antigen expression and cag A, CagA, vacA and VacA status of Irish Helicobacter pylori isolates. FEMS Immunol. Med. Microbiol. 1999, 24:79-90.
73. Matsumoto Y., Yuki N., Van Kaer L., Furukawa K., Hirata K., Sugita M. Cutting edge: Guillain-Barré syndrome-associated IgG responses to gangliosides are generated independently of CD1 function in mice. J. Immunol. 2008, 180:39-43.
74. Monteiro M.A. Helicobacter pylori: a wolf in sheep's clothing. The glyconjugate families of Helicobacter pylori lipopolysaccharides expressing histo-blood groups: structure, biosynthesis, and role in pathogenesis. Adv. Carbohydr. Chem. Biochem. 2001, 57:99-158.
75. Monteiro M.A., Michael F., Rasko D., et al. Helicobacter pylori from asymptomatic hosts expressing heptoglycan but lacking Lewis O-chains: Lewis blood-group O-chains may play a role in Helicobacter pylori induced pathology. Biochem. Cell Biol. 2001, 79:449-459.
76. Moran A.P. Cell surface characteristics of Helicobacter pylori. FEMS Immunol. Med. Microbiol. 1995, 10:271-280.
77. Moran A.P. Pathogenic properties of Helicobacter pylori. Scand. J. Gastroenterol. 1996, 31(Suppl. 215):22-31.
78. Moran A.P. Helicobacter pylori lipopolysaccharide-mediated gastric and extragastric pathology. J. Physiol. Pharmacol. 1999, 50:787-805.
79. Moran A.P. Helicobacter pylori lipopolysaccharides. Helicobacter pylori: Molecular and Cellular Biology 2001, 207-226. Horizon Scientific Press, Wymondham. M. Achtman, S. Suerbaum (Eds.).
80. Moran A.P. Molecular structure, biosynthesis and pathogenic roles of lipopolysaccharides. Helicobacter pylori: Physiology and Genetics 2001, 81-95. ASM Press, Washington, DC. H.L.T. Mobley, G.L. Mendz, S.L. Hazell (Eds.).
81. Moran A.P. Lipopolysaccharide in bacterial chronic infection: insights from Helicobacter pylori lipopolysaccharide and lipid A. Int. J. Med. Microbiol. 2007, 297:307-319.
82. Moran A.P. Relevance of fucosylation and Lewis antigen expression in the bacterial gastroduodenal pathogen Helicobacter pylori. Carbohydr. Res. 2008, 343:1952-1965.
83. Moran A.P., O'Malley D.T. Potential role of lipopolysaccharides of Campylobacter jejuni in the development of Guillain-Barré syndrome. J. Endotoxin Res. 1995, 2:233-235.
84. Moran A.P., Penner J.L. Serotyping of Campylobacter jejuni based on heat-stable antigens: relevance, molecular basis and implications in pathogenesis. J. Appl. Microbiol. 1999, 86:361-377.
85. Moran A.P., Prendergast M.M. Molecular mimicry in Campylobacter jejuni lipopolysaccharides and the development of Guillain-Barré syndrome. J. Infect. Dis. 1998, 178:1549-1550.
86. Moran A.P., Prendergast M.M. Molecular mimicry in Campylobacter jejuni and Helicobacter pylori lipopolysaccharides: contribution of gastrointestinal infections to autoimmunity. J. Autoimmun. 2001, 16:241-256.
87. Moran A.P., Trent M.S. Helicobacter pylori lipopolysaccharides and Lewis antigens. Helicobacter pylori: Molecular Genetics and Cellular Biology 2008, 7-36. Caister Academic Press, Norfolk. Y. Yamaoka (Ed.).
88. Moran A.P., Wadström T. Pathogenesis of Helicobacter pylori. Curr. Opin. Gastroenterol. 1998, 14(Suppl. 1):S9-S14.
89. Moran A.P., Rietschel E.T., Kosunen T.U., Zähringer U. Chemical characterization of Campylobacter jejuni lipopolysaccharides containing N-acetylneuraminic acid and 2,3-diamino-2,3-dideoxy-d-glucose. J. Bacteriol. 1991, 173:618-626.
90. Moran A.P., Appelmelk B.J., Aspinall G.O. Molecular mimicry of host structures by lipopolysaccharides of Campylobacter and Helicobacter spp.: implications in pathogenesis. J. Endotoxin Res. 1996, 3:521-531.
91. Moran A.P., Lindner B., Walsh E.J. Structural characterization of the lipid A component of Helicobacter pylori rough- and smooth-form lipopolysaccharides. J. Bacteriol. 1997, 179:6453-6463.
92. Moran A., Penner J., Aspinall G. Campylobacter lipopolysaccharides. Campylobacter 2000, 241-257. ASM Press, Washington, DC. 2nd edn. I. Nachamkin, M.J. Blaser (Eds.).
93. Moran A.P., Sturegård E., Sjunnesson H., Wadström T., Hynes S.O. The relationship between O-chain expression and colonisation ability of Helicobacter pylori in a mouse model. FEMS Immunol. Med. Microbiol. 2000, 29:263-270.
94. Moran A.P., Kosunen T.U., Prendergast M.M. Biochemical and serological analysis of the heat-stable antigens involved in serotyping Campylobacter jejuni/coli. Int. J. Med. Microbiol. 2001, 291(Suppl. 31):72.
95. y expression by H. pylori lipopolysaccharides. J. Biol. Chem. 2002, 277:5785-5795.
96. Moran A.P., Prendergast M.M., Hogan E.L. Sialosyl-galactose: a common denominator of Guillain-Barré and related disorders?. J. Neurol. Sci. 2002, 196:1-7.
97. Moran A.P., Ferris J.A., Perepelov A.V., et al. Structural examination of Lewis expression and adaptation in lipopolysaccharides of Helicobacter pylori from experimentally infected rhesus monkeys. Gut 2002, 51(Suppl. II):A15.
98. Moran A.P., Perepelov A.V., Knirel Y.A., Amano K.-i., McGovern J.J., Jansson P.-E. Lewis expression on LPS of Japanese Helicobacter pylori-associated cancer strains and importance of serological test format for detection. J. Endotoxin Res. 2004, 10:315.
99. Moran A.P., Annuk H., Prendergast M.M. Antibodies induced by ganglioside-mimicking Campylobacter jejuni lipooligosaccharides recognise epitopes at the nodes of Ranvier. J. Neuroimmunol. 2005, 165:179-185.
100. Moran A.P., Kharmi W., Walker M.M., Thursz M.R. Role of surfactant protein D (SP-D) in innate immunity in the gastric mucosa: evidence of interaction with Helicobacter pylori lipopolysaccharide. J. Endotoxin Res. 2005, 11:357-362.
101. y, CA19-9, and CSLEX1 in early cancer, intestinal metaplasis, and uninvolved mucosa of the stomach. Am. J. Clin. Pathol. 1992, 98:67-75.
102. Murray E., Khamri W., Walker M.M., et al. Expression of surfactant protein D in human gastric mucosa and Helicobacter pylori infection. Infect. Immun. 2002, 70:1481-1487.
103. Nachamkin I., Ung H., Moran A.P., et al. Ganglioside GM1 mimicry in Campylobacter strains from sporadic infections in the United States. J. Infect. Dis. 1999, 179:1183-1189.
104. Negrini R., Lisato L., Zanella I., et al. Helicobacter pylori infection induces antibodies cross-reacting with human gastric mucosa. Gastroenterology 1991, 101:437-445.
105. Negrini R., Savio A., Poiesi C., et al. Antigenic mimicry between Helicobacter pylori and gastric mucosa in the pathogenesis of body atrophic gastritis. Gastroenterology 1996, 111:655-665.
106. Neisser A., Bernheimer H., Berger T., Moran A.P., Schwerer B. Serum antibodies against gangliosides and Campylobacter jejuni lipopolysaccharides in Miller Fisher syndrome. Infect. Immun. 1997, 65:4038-4042.
107. Neisser A., Schwerer B., Bernheimer H., Moran A.P. Ganglioside-induced antiganglioside antibodies from a neuropathy patient cross-react with lipopolysaccharides of Campylobacter jejuni associated with Guillain-Barré syndrome. J. Neuroimmunol. 2000, 102:85-88.
108. Nilsson C., Skoglund A., Moran A.P., Annuk A., Engstrand L., Normark S. An enzymatic ruler modulates Lewis antigen glycosylation of Helicobacter pylori LPS during persistent infection. Proc. Natl. Acad. Sci. USA 2006, 103:2863-2868.
109. Nilsson C., Skoglund A., Moran A.P., Annuk H., Engstrand L., Normark S. Lipopolysaccharide diversity evolving in Helicobacter pylori communities through genetic modifications in fucosyltransferases. PLoS ONE 2008, 3:e3811.
110. Notterpek L., Tolwani R.J. Experimental models of peripheral neuropathies. Lab. Animal Sci. 1999, 49:588-599.
111. O'Keeffe J., Moran A.P. Conventional, regulatory and unconventional T-cells in the immunological response to Helicobacter pylori. Helicobacter 2008, 13:1-19.
112. Olson J.K., Ercolini A.M., Miller S.D. A virus-induced molecular mimicry model of multiple sclerosis. Curr. Top. Microbiol. Immunol. 2005, 296:39-53.
113. 1 antibodies cloned from motor neuropathy patients demonstrates diverse variable region gene usage with extensive somatic mutation. J. Immunol. 1995, 155:3049-3059.
114. Poly F., Read T.D., Chen Y.H., et al. Characterization of two Campylobacter jejuni strains for use in volunteer experimental-infection studies. Infect. Immun. 2008, 76:5655-5667.
115. Prendergast M.M., Moran A.P. Lipopolysaccharides in the development of the Guillain-Barré syndrome and Miller Fisher syndome forms of acute inflammatory peripheral neuropathies. J. Endotoxin Res. 2000, 6:341-359.
116. 1 ganglioside. Infect. Immun. 1998, 66:3649-3655.
117. 1 ganglioside show diverse cross-reactivity with lipopolysaccharides of Campylobacter jejuni strains associated with Guillain-Barré syndrome. Infect. Immun. 1999, 67:3698-3701.
118. Prendergast M.M., Tribble D.R., Baqar S., et al. In vivo phase variation and serological response to lipooligosaccharide of Campylobacter jejuni in experimental human infection. Infect. Immun. 2004, 72:916-922.
119. Rieder G., Hatz R.A., Moran A.P., Walz A., Stolte M., Enders G. Role of adherence in interleukin-8 induction in Helicobacter pylori-associated gastritis. Infect. Immun. 1997, 65:3622-3630.
120. 2 ganglioside after immunization with lipopolysaccharides from Campylobacter jejuni. Int. J. Cancer 1996, 66:184-190.
121. Saida T., Saida K., Lisak R.P., Brown M.J., Silberberg D.H., Asbury A.K. In vivo demyelinating activity of sera from patients with Guillain-Barré syndrome. Ann. Neurol. 1982, 11:69-75.
122. Sakamoto J., Yin B.T., Lloyd K.O. Analysis of the expression of H, Lewis, X, Y and precursor blood group determinants in saliva and red cells using a panel of mouse monoclonal antibodies. Mol. Immunol. 1984, 21:1093-1098.
123. x blood group antigens in human gastric carcinoma and in normal gastric tissue. Cancer Res. 1989, 49:745-752.
124. Schwerer B., Neisser A., Polt R.J., Bernheimer H., Moran A.P. Antibody crossreactivities between gangliosides and lipopolysaccharides of Campylobacter jejuni serotypes associated with Guillain-Barré syndrome. J. Endotoxin Res. 1995, 2:395-403.
125. Senchenkova S.N., Zatonsky G.V., Hynes S.O., et al. Structure of a d-glycero-d-manno-heptan from the lipopolysaccharide of Helicobacter pylori. Carbohydr. Res. 2001, 331:219-224.
126. Sieling P.A., Chatterjee D., Porcelli S.A., et al. CD1-restricted T-cell recognition of microbial lipoglycans. Science 1995, 269:227-230.
127. 2) on human granulocytes. J. Leukocyte Biol. 1993, 53:541-549.
128. Sumner A., Said G., Idy I., Metral S. Demyelinative conduction block produced by intraneural injection of human Guillain-Barré serum into rat sciatic nerve. Neurology 1982, 32:106.
129. Sun H.Y., Lin S.W., Ko T.P., et al. Structure and mechanism of H. pylori fucosyltransferase. A basis for lipopolysaccharide variation and inhibitor design. J. Biol. Chem. 2007, 282:9973-9982.
130. Takata T., El-Omar E., Camorlinga M., et al. Helicobacter pylori does not require Lewis X and Lewis Y expression to colonize C3H/HeJ mice. Infect. Immun. 2002, 70:3073-3079.
131. Taylor D.E., Rasko D.A., Sherburne R., Ho C., Jewell L.D. Lack of correlation between Lewis antigen expression by Helicobacter pylori and gastric epithelial cells in infected patients. Gastroenterology 1998, 115:1113-1122.
132. Taylor W.A., Hughes R.A.C. T lymphocyte activation antigens in Guillain-Barré syndrome and chronic idiopathic demyelinating polyradiculoneuropathy. J. Neuroimmunol. 1989, 24:33-39.
133. + T-cell subsets. Proc. Natl. Acad. Sci. USA 1994, 91:18-22.
134. Vorobjova T., Faller G., Maaroos H.-I., et al. Significant increase in antigastric autoantibodies in a long-term follow-up study of H. pylori gastritis. Virchows Arch. 2000, 437:37-45.
135. Westall F.C. Molecular mimicry revisited: gut bacteria and multiple sclerosis. J. Clin. Microbiol. 2006, 44:2099-2104.
136. Willison H.J., O'Hanlon G.M. Anti-glycospingolipid antibodies and Guillain-Barré syndrome. Campylobacter 2000, 259-285. ASM Press, Washington, DC. 2nd edn. I. Nachamkin, M.J. Blaser (Eds.).
137. 1b antibodies in Miller Fisher syndrome. J. Neuroimmunol. 1994, 50:159-165.
138. 1 antibodies by Campylobacter jejuni lipopolysaccharides. J. Neuroimmunol. 1997, 78:138-142.
139. Wirth H.P., Yang M., Karita M., Blaser M.J. Expression of the human cell surface glycoconjugates Lewis X and Lewis Y by Helicobacter pylori isolates is related to cagA status. Infect. Immun. 1996, 64:4598-4605.
140. Wirth H.P., Yang M., Peek R.M., Tham K.T., Blaser M.J. Helicobacter pylori Lewis expression is related to the host Lewis phenotype. Gastroenterology 1997, 113:1091-1098.
141. Wirth H.P., Yang M., Peek R.M., Höök-Nikanne J., Fried M., Blaser M.J. Phenotypic diversity in Lewis expression of Helicobacter pylori isolates from the same strain. J. Lab. Clin. Med. 1999, 133:488-500.
142. Wirth H.P., Yang M., Sanabria-Valentin E., Berg D.E., Dubois A., Blaser M.J. Host Lewis phenotype-dependent Helicobacter pylori Lewis antigen expression in rhesus monkeys. FASEB J. 2006, 20:1534-1536.
143. Yuki N. Infectious origins of, and molecular mimicry in, Guillain-Barré and Fischer syndromes. Lancet Infect. Dis. 2001, 1:29-37.
144. Yuki N. Carbohydrate mimicry: a new paradigm of autoimmune diseases. Curr. Opin. Immunol. 2005, 17:577-582.
145. Yuki N. Ganglioside mimicry and peripheral nerve disease. Muscle Nerve 2007, 35:691-711.
146. 1 ganglioside-like structure. J. Exp. Med. 1993, 178:1771-1775.
147. Yuki N., Yamada M., Koga M., et al. Aninal model of axonal Guillain-Barré syndrome induced by sensitization with GM1 ganglioside. Ann. Neurol. 2001, 49:712-720.
148. Yuki N., Susuki K., Koga M., et al. Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain-Barré syndrome. Proc. Natl. Acad. Sci. USA 2004, 101:11404-11409.
149. Zandman-Goodard G., Shoenfeld Y. Infections and SLE. Autoimmunity 2005, 38:473-485.